Detalhe da pesquisa
1.
What Came First-the Virus or the Egg?
Cell
; 168(5): 755-757, 2017 02 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-28235193
2.
Envelope residue 375 substitutions in simian-human immunodeficiency viruses enhance CD4 binding and replication in rhesus macaques.
Proc Natl Acad Sci U S A
; 113(24): E3413-22, 2016 06 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-27247400
3.
A Haploid Genetic Screen Identifies Heparan Sulfate Proteoglycans Supporting Rift Valley Fever Virus Infection.
J Virol
; 90(3): 1414-23, 2016 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26581979
4.
The major cellular sterol regulatory pathway is required for Andes virus infection.
PLoS Pathog
; 10(2): e1003911, 2014 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-24516383
5.
Simultaneous zinc-finger nuclease editing of the HIV coreceptors ccr5 and cxcr4 protects CD4+ T cells from HIV-1 infection.
Blood
; 123(1): 61-9, 2014 Jan 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-24162716
6.
Phenotypic properties of transmitted founder HIV-1.
Proc Natl Acad Sci U S A
; 110(17): 6626-33, 2013 Apr 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-23542380
7.
Transmitted/founder and chronic HIV-1 envelope proteins are distinguished by differential utilization of CCR5.
J Virol
; 87(5): 2401-11, 2013 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-23269796
8.
Transmitted/founder and chronic subtype C HIV-1 use CD4 and CCR5 receptors with equal efficiency and are not inhibited by blocking the integrin α4ß7.
PLoS Pathog
; 8(5): e1002686, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22693444
9.
Kruppel-like factor 2 modulates CCR5 expression and susceptibility to HIV-1 infection.
J Immunol
; 189(8): 3815-21, 2012 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-22988032
10.
Engineering HIV-resistant human CD4+ T cells with CXCR4-specific zinc-finger nucleases.
PLoS Pathog
; 7(4): e1002020, 2011 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-21533216
11.
Yeast-elicited cross-reactive antibodies to HIV Env glycans efficiently neutralize virions expressing exclusively high-mannose N-linked glycans.
J Virol
; 85(1): 470-80, 2011 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-20962094
12.
Phenotypic and immunologic comparison of clade B transmitted/founder and chronic HIV-1 envelope glycoproteins.
J Virol
; 85(17): 8514-27, 2011 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-21715507
13.
Primary infection by a human immunodeficiency virus with atypical coreceptor tropism.
J Virol
; 85(20): 10669-81, 2011 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-21835785
14.
Molecular mechanisms of HIV entry.
Adv Exp Med Biol
; 726: 223-42, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22297516
15.
Comparative Evaluation of Choose Your Own Adventure and Traditional Linear Case Formats in Radiology Small Group Teaching.
Acad Radiol
; 29 Suppl 5: S82-S88, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34987000
16.
HIV-1 resistance to CCR5 antagonists associated with highly efficient use of CCR5 and altered tropism on primary CD4+ T cells.
J Virol
; 84(13): 6505-14, 2010 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-20410277
17.
A maraviroc-resistant HIV-1 with narrow cross-resistance to other CCR5 antagonists depends on both N-terminal and extracellular loop domains of drug-bound CCR5.
J Virol
; 84(20): 10863-76, 2010 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-20702642
18.
Antibodies against Manalpha1,2-Manalpha1,2-Man oligosaccharide structures recognize envelope glycoproteins from HIV-1 and SIV strains.
Glycobiology
; 20(3): 280-6, 2010 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-19920089
19.
Use of a small molecule CCR5 inhibitor in macaques to treat simian immunodeficiency virus infection or prevent simian-human immunodeficiency virus infection.
J Exp Med
; 198(10): 1551-62, 2003 Nov 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-14623909
20.
HR-2 mutations in human immunodeficiency virus type 1 gp41 restore fusion kinetics delayed by HR-1 mutations that cause clinical resistance to enfuvirtide.
J Virol
; 83(7): 2989-95, 2009 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-19153234